{"id":"NCT05061992","sponsor":"University of Michigan","briefTitle":"A Trial to Improve Quality of Life in People With Cirrhosis","officialTitle":"A Trial to Improve Quality of Life in People With Cirrhosis - the Michigan Kristalose Trial","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2021-11-10","primaryCompletion":"2022-11-01","completion":"2022-11-01","firstPosted":"2021-09-30","resultsPosted":"2023-11-21","lastUpdate":"2023-11-21"},"enrollment":56,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cirrhosis"],"interventions":[{"type":"DRUG","name":"Lactulose","otherNames":["Kristalose"]}],"arms":[{"label":"Lactulose","type":"EXPERIMENTAL"},{"label":"No treatment","type":"NO_INTERVENTION"}],"summary":"This trial is being completed to evaluate whether a crystallized form of lactulose (Kristalose) will improve quality of life, sleep and cognitive function in patients with cirrhosis that have not been diagnosed with Hepatic Encephalopathy (HE), but report reduced quality of life.","primaryOutcome":{"measure":"Short Form-8 Health Survey (SF-8) at 28 Days","timeFrame":"28 days","effectByArm":[{"arm":"Lactulose","deltaMin":8.1,"sd":null},{"arm":"No Treatment","deltaMin":6.55,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6"},{"comp":"OG000 vs OG001","p":"0.2"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":28},"commonTop":["Fall"]}}